Back

Remnant cholesterol, clinical characteristics and mortality in 41.767 patients from LIPIDOGRAM 2004-2015 studies - the factor analysis for mixed data cluster analysis

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Lipoproteins and cardiovascular risk Lipids ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Professor Maciej Banach

Medical University of Lodz, Lodz (Poland)

7 More presentations in this session

Presentation thumbnail
Sex-specific guideline target value attainment and prognostic value of low-density lipoprotein cholesterol in tertiary care
Ms K. Rumora (Basel, CH)
Abstract Slides Video
Presentation thumbnail
Circulating Amyloid beta 1-40 is independently associated with statin treatment and LDL cholesterol reduction: a prospective cohort study
Doctor E. Aivalioti (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Factors influencing low-density-lipoprotein cholesterol after acute coronary syndrome and effectiveness of intensive teleconsultation monitoring, the teleobjectif cohort study
Doctor A. Lemaitre (Caen, FR)
Abstract Slides Video
Presentation thumbnail
Relationship of cumulative low-density lipoprotein cholesterol with atherosclerosis
Doctor T. Yamaji (Hiroshima, JP)
Abstract Slides Video
Presentation thumbnail
Effects of Chios Mastiha essential oil on cholesterol levels of healthy volunteers: a prospective, randomized, placebo-controlled study.
Doctor D. Afendoulis (Athens, GR)
Abstract Slides Video

Access the full session

Session thumbnail
Lipoproteins and cardiovascular risk

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Remnant cholesterol and risk of coronary heart disease beyond LDL-cholesterol and HDL-cholesterol: a population-based prospective cohort study
thumbnail
Congress Presentation
Remnant cholesterol and cardiovascular and all-cause mortality in Korean adults
thumbnail
Congress Presentation
Remnant cholesterol is a predictor for all-cause mortality in coronary artery disease patients independent of the total ApoB-particle count

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources